Health knowledge made personal
Join this community!
› Share page:
Search posts:

Gluten in Medications Education Seminar

Posted Jul 03 2008 1:14pm

Approximately 3 million Americans may have celiac disease, an autoimmune  disorder triggered by the consumption of gluten, a protein found in wheat, barley, and rye. The Food Allergen Labeling Consumer Protection Act of 2004, which requires packaged food labels to name all ingredients containing wheat and other common allergens, was a major landmark for patients with celiac disease and food allergens. Yet no similar requirement exists for medication labels. On Friday, April 11, the National Foundation for Celiac Awareness, the American Society of Health-System Pharmacists and Giant Pharmacy will host a Gluten in Medications event for pharmacists and pharmaceutical manufacturers.

The event will feature 1.5 hours continuing education, sponsored by ASHP, followed by a two-hour stakeholders meeting examining issues involved in labeling derivative sources of excipients in medications. The CE program will focus on educating pharmacists about celiac disease, the issues of gluten in medication, and how celiac disease may affect normal absorption of both prescription and non-prescription drugs.

Who should attend:Pharmacists who practice in hospitals and health systems, community pharmacies, chain and grocery stores pharmacies; as well as pharmaceutical company representatives and national pharmacy organizations; other medical professionals and dietitians.

Learning objectives:Upon completion of the CE program, attendees will be able to define celiac disease and its pathophysiology; articulate the suspected incidence of celiac disease; list signs and symptoms; describe potential sources of gluten in medication; identify reactions celiac patients may have from drugs; describe current United States and International guidelines for labeling; and discuss ways that pharmacists and pharmaceutical manufacturers can help patients with celiac disease use medicines safely.

Date: Friday April 11, 2008

2:00-3:30pm Continuing Education Session (ACPE Program #204-000-079-L04-P)

3:45:-5:45pm Stakeholders Discussion


Hyatt Regency Bethesda

7400 Wisconsin Ave

Bethesda, MD 20814

*Discounted hotel rates are available at the Hyatt Regency Bethesda. Please call the hotel directly and reference the NFCA Block to receive the discount.


2:00 p.m. Welcome

2:05 p.m. What is Celiac Disease?

Aline Charabaty, M.D., Gastroenterologist, Georgetown University Hospital 

2:20 p.m. Gluten in Medication & When is Gluten-Free Really Gluten-Free?

Robert Mangione, R.Ph., Ed.D., Dean of the St. Johns University College of Pharmacy

2:35 p.m. Parallels with the Food Allergen Labeling and Consumer Protection Act

Rhonda Kane, M.S., R.D., Consumer Safety Officer FDA Office of Nutrition, Labeling, and Dietary Supplements Center for Food Safety and Applied Nutrition

2:50 p.m. Excipients & Stakeholders

Gerry McEvoy, Pharm.D., ASHP Vice President, Drug Information

3:05 p.m. USP: Opportunities to Address Labeling Issues

Andrzej Wilk, Ph.D., Senior Scientist, United States Pharmacopeia

3:20 p.m. What You Can Do to Help Celiac Patients

Vanessa Maltin, Director of Programming & Communications, National Foundation for Celiac Awareness

To register for the Gluten in Medications Education Day, please visit:

Post a comment
Write a comment:

Related Searches